Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Impaired Ectodysplasin A (EDA) – EDA receptor (EDAR) signaling affects ectodermally derived structures including teeth, hair follicles and cutaneous glands. X-linked hypohidrotic ectodermal dysplasia (XLHED), resulting from EDA deficiency, can be rescued with lifelong benefits in animal models by stimulation of ectodermal appendage development with EDAR agonists. Treatments initiated later in the developmental period restore progressively fewer of the affected structures. It is unknown whether EDAR stimulation in adults with XLHED might have beneficial effects. In adult Eda mutant mice treated for several weeks with agonist anti-EDAR antibodies, we find that sebaceous glands size and function can be restored to wild type levels. This effect is maintained upon chronic treatment but reverses slowly upon cessation of treatment. Sebaceous glands in all skin regions respond to treatment, though to varying degrees, and this is accompanied in both Eda mutant and wild type mice by sebum secretion to levels higher than those observed in untreated controls. Edar is expressed at the periphery of the glands, suggesting a direct homeostatic effect of Edar stimulation on the sebaceous gland. Sebaceous gland size and sebum production may serve as biomarkers for EDAR stimulation, and EDAR agonists may improve skin dryness and eczema frequently observed in XLHED.
Impaired Ectodysplasin A (EDA) – EDA receptor (EDAR) signaling affects ectodermally derived structures including teeth, hair follicles and cutaneous glands. X-linked hypohidrotic ectodermal dysplasia (XLHED), resulting from EDA deficiency, can be rescued with lifelong benefits in animal models by stimulation of ectodermal appendage development with EDAR agonists. Treatments initiated later in the developmental period restore progressively fewer of the affected structures. It is unknown whether EDAR stimulation in adults with XLHED might have beneficial effects. In adult Eda mutant mice treated for several weeks with agonist anti-EDAR antibodies, we find that sebaceous glands size and function can be restored to wild type levels. This effect is maintained upon chronic treatment but reverses slowly upon cessation of treatment. Sebaceous glands in all skin regions respond to treatment, though to varying degrees, and this is accompanied in both Eda mutant and wild type mice by sebum secretion to levels higher than those observed in untreated controls. Edar is expressed at the periphery of the glands, suggesting a direct homeostatic effect of Edar stimulation on the sebaceous gland. Sebaceous gland size and sebum production may serve as biomarkers for EDAR stimulation, and EDAR agonists may improve skin dryness and eczema frequently observed in XLHED.
Christ – Siemens – Touraine syndrome is a genetically determined disease, mainly of males, the female is carriers of the pathogenic gene. The incidence of the disease has not been precisely established, according to modern data 1 case on 5 000–10 000 newborns, in female carriers 17 cases 100 000. Usually, the syndrome is inherited linked to gender, but autosomal and spontaneous forms are possible. There is a mutation of the EDA1 gene encoding the synthesis of ectodysplasin-A. As a result, epithelial and mesenchymal interactions are disrupted, leading to a lack of regulation of the formation of epithelial appendages. There are phenotypic specific features: thick lips, triangular lower jaw, wide saddle-shaped bridge of the nose and deformed low-set ear, wide cheekbones, fine wrinkled and hyperpigmented skin around the eyes, agenesis of the mammary glands in women. A clinical triad of signs is characteristic: hypotrichosis/atrichosis (thin, light, dry hair); hypodontia/anodontia (conical teeth); hypohidrosis/anhidrosis (a condition that threatens the death of a child due to hyperthermia). The authors presented a clinical case of hereditary Christ – Siemens – Touraine syndrome in a newborn child. The documentation was used when writing the article, we was used the medical history of the department of pathology of newborn children and young children of Tyumen regional clinical hospital No. 2 and was analyzed scientific articles about this theme in the open scientific databases, such as PubMed, Elsiver, Springer and Russian scientific electronic library. The presence of specific phenotypic and clinical signs makes it possible to diagnose the syndrome immediately after birth. Based on the datas of medical history, a burdened genealogical history, the initial the patient examination allowed to identify numerous stigmas of dysembriogenesis and malformations that confirmed the rare hereditary Christ – Siemens – Touraine syndrome. Christ-Siemens-Touraine syndrome is a risk factor for skin diseases, respiratory system and teeth, which must be taken into account for early diagnosis and determination of further patient management tactics by a pediatrician, dermatologist and dentist.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.